Welcome to our dedicated page for Iradimed news (Ticker: IRMD), a resource for investors and traders seeking the latest updates and insights on Iradimed stock.
iRadimed Corporation reports news on its MRI-compatible medical-device business, including non-magnetic IV infusion pump systems, patient vital signs monitoring systems, accessories, disposables and related services sold to hospitals and acute care facilities. Company updates often describe financial results, revenue and earnings guidance, cash generation, and regular or special cash dividends.
IRMD news also covers product activity for systems such as the 3880 MRI-compatible patient vital signs monitor and the next-generation 3870 MRI-compatible IV infusion pump, along with investor conference participation and recognition tied to growth and financial performance.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
IRADIMED CORPORATION (NASDAQ: IRMD) will announce its 2023 first quarter financial results before markets open on May 4th, followed by a conference call at 11:00 a.m. ET. Interested participants can register online to join the call, which will also be streamed live on their website. The company is known for its innovative MRI-compatible medical devices, including the MRidium® IV infusion pump and the iRadimed 3880 vital signs monitoring system, designed for safety and efficiency during MRI procedures. These products utilize non-magnetic components to eliminate risks associated with traditional devices in high-field MRI environments, enhancing patient care.